At the time of writing, CVS Health Corp [CVS] stock is trading at $61.61, up 11.33%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CVS shares have gain 9.26% over the last week, with a monthly amount drifted -6.51%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
CVS Health Corp [NYSE: CVS] stock has seen the most recent analyst activity on October 10, 2024, when Barclays upgraded its rating to a Overweight and also boosted its price target to $82 from $63. Previously, TD Cowen upgraded its rating to Buy on October 04, 2024, and elevated its price target to $85. On May 30, 2024, Robert W. Baird initiated with a Neutral rating and assigned a price target of $61 on the stock. TD Cowen downgraded its rating to a Hold and decreased its price target to $59 on May 07, 2024. UBS downgraded its rating to a Neutral and reduced its price target to $60 on May 02, 2024. Leerink Partners downgraded its rating to Market Perform for this stock on May 01, 2024, and downed its price target to $60. In a note dated May 01, 2024, Cantor Fitzgerald downgraded an Neutral rating on this stock.
For the past year, the stock price of CVS Health Corp fluctuated between $52.77 and $83.25. Currently, Wall Street analysts expect the stock to reach $100.09 within the next 12 months. CVS Health Corp [NYSE: CVS] shares were valued at $61.61 at the most recent close of the market. An investor can expect a potential return of 62.46% based on the average CVS price forecast.
Analyzing the CVS fundamentals
According to CVS Health Corp [NYSE:CVS], the company’s sales were 363.65B for trailing twelve months, which represents an 2.59% jump. Gross Profit Margin for this corporation currently stands at 0.14% with Operating Profit Margin at 0.03%, Pretax Profit Margin comes in at 0.03%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.1 and Total Capital is 0.07. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.91.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 60.51 points at the first support level, and at 59.41 for the second support level. However, for the 1st resistance point, the stock is sitting at 63.02, and for the 2nd resistance point, it is at 64.43.
Ratios To Look Out For
It is important to note that CVS Health Corp [NYSE:CVS] has a current ratio of 0.86. Also, the Quick Ratio is 0.66, while the Cash Ratio stands at 0.15. Considering the valuation of this stock, the price to sales ratio is 0.21, the price to book ratio is 1.03 and price to earnings (TTM) ratio is 10.96.
Transactions by insiders
Recent insider trading involved LUDWIG EDWARD J, Director, that happened on May 02 ’24 when 1000.0 shares were purchased. Director, Mahoney Michael F completed a deal on May 02 ’24 to buy 9181.0 shares. Meanwhile, EVP and Pres-Pharm, Consumer W Shah Prem S sold 29473.0 shares on Feb 16 ’24.
